Skip to main content
Equibles

UBS Group AG

Position in IPHA — Innate Pharma SA

CIK 1610520 ZURICH, V8
Back to IPHA Full portfolio

Position in IPHA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,507
+$1,406 QoQ
Shares Held
1,363
+58.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 10 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IPHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. IPHA ranks #494 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in IPHA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,507 1,363
2026-03-31 $1,101 861
2025-12-31 $1,656 947
2025-09-30 $9,258 4,797
2025-06-30 $10,811 5,957
2025-03-31 $16,020 9,001
2024-12-31 $6,457 3,510
2024-09-30 $19,253 8,408
2024-06-30 $575 297
2024-03-31 $604 210
2023-12-31 $408 146
2023-09-30 $369 146
2023-06-30 $448 146
2023-03-31 $3,588 1,259
2022-12-31 $544 146
2022-09-30 $9,010 4,505
2022-06-30 $7,981 2,956